Clinical significance of vasculogenic mimicry in human gliomas.

Mechanisms of glioma-associated neovascularization. Am J Pathol (2012) 1.39

Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med (Berl) (2013) 1.31

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathol (2012) 1.30

Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation. J Biol Chem (2012) 1.16

Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci (2012) 1.10

Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis. Oncotarget (2014) 0.95

Vasculogenic mimicry: a novel target for glioma therapy. Chin J Cancer (2013) 0.95

Glioma-related edema: new insight into molecular mechanisms and their clinical implications. Chin J Cancer (2012) 0.90

Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases. BMC Cancer (2014) 0.89

Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity. PLoS One (2013) 0.87

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget (2015) 0.83

Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets. PLoS One (2013) 0.81

Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets. Biomark Res (2015) 0.81

Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma. Int J Nanomedicine (2016) 0.79

B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry. Clin Exp Med (2012) 0.78

Glioblastoma: Defining Tumor Niches. Trends Cancer (2015) 0.78

Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model. BMC Cancer (2017) 0.75

Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response. Oncotarget (2015) 0.75

M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells. Oncotarget (2016) 0.75

Curcumin inhibits vasculogenic mimicry through the downregulation of erythropoietin-producing hepatocellular carcinoma-A2, phosphoinositide 3-kinase and matrix metalloproteinase-2. Oncol Lett (2014) 0.75

Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy. Theranostics (2016) 0.75

Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation. Oncotarget (2016) 0.75

Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells. Autophagy (2017) 0.75

Transcription Factor NFAT5 Promotes Glioblastoma Cell-driven Angiogenesis via SBF2-AS1/miR-338-3p-Mediated EGFL7 Expression Change. Front Mol Neurosci (2017) 0.75

Overexpression of leptin receptor in human glioblastoma: Correlation with vasculogenic mimicry and poor prognosis. Oncotarget (2017) 0.75

Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma. Transl Oncol (2017) 0.75

The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66

Glioblastoma stem-like cells give rise to tumour endothelium. Nature (2010) 6.18

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer (2003) 3.93

A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain (2010) 3.53

Vasculogenic mimicry and tumor angiogenesis. Am J Pathol (2000) 3.19

Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer (1996) 2.18

Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res (2002) 1.64

Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int J Cancer (2001) 1.61

Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods. Am J Clin Pathol (1996) 1.60

Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem (2005) 1.37

Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate (2002) 1.32

Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol (2004) 1.27

A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res (2006) 1.24

Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Res (2005) 1.21

The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy. Cancer Biol Ther (2003) 1.15

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg (1999) 1.13

ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma model. Mol Cancer Ther (2003) 1.12

Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol (2008) 1.11

A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch Pathol Lab Med (2007) 1.09

Prognostic role of vasculogenic mimicry in colorectal cancer. Dis Colon Rectum (2009) 1.09

Vasculogenic mimicry of acute leukemic bone marrow stromal cells. Leukemia (2009) 1.06

Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus. J Pathol (2004) 1.06

Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry. Chin Med J (Engl) (2004) 1.03

Microcirculation patterns in different stages of melanoma growth. Oncol Rep (2006) 1.01

Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg (1998) 0.99

Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas. Neuropathol Appl Neurobiol (2006) 0.96

Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma. Can J Urol (2009) 0.93

Glioma stem cells involved in tumor tissue remodeling in a xenograft model. J Neurosurg (2010) 0.92

Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy. J Neurosurg (1995) 0.90

Study on vasculogenic mimicry in malignant esophageal stromal tumors. World J Gastroenterol (2008) 0.84

Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. Hum Pathol (2004) 0.81

International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol (2014) 3.21

Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol (2012) 2.34

Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport (2002) 1.55

Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro Oncol (2009) 1.51

Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res (2011) 1.36

Oncogenic role of microRNAs in brain tumors. Acta Neuropathol (2009) 1.30

CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol (2014) 1.28

Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. J Clin Oncol (2011) 1.23

TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. Int J Cancer (2009) 1.13

Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J Neurochem (2002) 1.11

Distribution of human papillomavirus types in cervical cancers in Hong Kong: current situation and changes over the last decades. Int J Cancer (2009) 1.08

Persistent infection of SARS coronavirus in colonic cells in vitro. J Med Virol (2004) 1.07

Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors. BMC Cancer (2012) 1.06

miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. Cancer Chemother Pharmacol (2013) 1.02

Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS). Mod Pathol (2005) 1.01

Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease. J Neurosci (2010) 1.00

Glioblastoma stem cells resistant to temozolomide-induced autophagy. Chin Med J (Engl) (2009) 0.98

Mutation analysis of IDH1 in paired gliomas revealed IDH1 mutation was not associated with malignant progression but predicted longer survival. PLoS One (2013) 0.96

Role of the RARRES1 gene in nasopharyngeal carcinoma. Cancer Genet Cytogenet (2009) 0.96

Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization. J Neurosurg (2004) 0.95

Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression. Pharmacogenet Genomics (2008) 0.95

Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies. Int J Cancer (2010) 0.94

Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis. Clin Cancer Res (2005) 0.92

MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. BMC Cancer (2014) 0.91

TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells. Neuro Oncol (2013) 0.91

Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor. Hum Pathol (2005) 0.91

Neuropathology of cigarette smoking. Acta Neuropathol (2013) 0.90

Surgical management of radiation-induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: report of 14 cases. Head Neck (2010) 0.89

Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center. Tumour Biol (2011) 0.89

MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). Brain Pathol (2013) 0.89

Genome-wide survey for chromosomal imbalances in ganglioglioma using comparative genomic hybridization. Cancer Genet Cytogenet (2002) 0.88

Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines. Ai Zheng (2002) 0.88

Clinical significance of B7-H4 expression in matched non-small cell lung cancer brain metastases and primary tumors. Onco Targets Ther (2013) 0.88

Clonality of oligoastrocytomas. Hum Pathol (2002) 0.88

AluScan: a method for genome-wide scanning of sequence and structure variations in the human genome. BMC Genomics (2011) 0.87

EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q. Int J Cancer (2007) 0.87

High signal on T1 sequence of magnetic resonance imaging confirmed to be intraplaque haemorrhage by histology in middle cerebral artery. Int J Stroke (2014) 0.87

Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma. J Pathol (2010) 0.86

miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN. Neuropathol Appl Neurobiol (2015) 0.86

MiR-22 is frequently downregulated in medulloblastomas and inhibits cell proliferation via the novel target PAPST1. Brain Pathol (2014) 0.85

Genetic imbalances in pleomorphic xanthoastrocytoma detected by comparative genomic hybridization and literature review. Cancer Genet Cytogenet (2002) 0.85

Whole genome amplification for array comparative genomic hybridization using DNA extracted from formalin-fixed, paraffin-embedded histological sections. J Mol Diagn (2009) 0.85

Single nucleotide polymorphisms and expression of ERCC1 and ERCC2 vis-à-vis chemotherapy drug cytotoxicity in human glioma. J Neurooncol (2006) 0.85

New testing approach in HLA genotyping helps overcome barriers in effective clinical practice. Clin Chem (2009) 0.84

[Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma]. Ai Zheng (2004) 0.84

Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy. Hum Genet (2013) 0.84

Genome-wide allelotype study of primary glioblastoma multiforme. Chin Med J (Engl) (2003) 0.83

Dyslexia-associated kiaa0319-like protein interacts with axon guidance receptor nogo receptor 1. Cell Mol Neurobiol (2010) 0.83

Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Acta Neuropathol (2012) 0.83

Chromosome 14q may harbor multiple tumor suppressor genes in primary glioblastoma multiforme. Chin Med J (Engl) (2002) 0.83

MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. Brain Pathol (2013) 0.82

Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors. Pediatr Blood Cancer (2013) 0.82

Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors. Int J Cancer (2003) 0.82

Low molecular weight Abeta induces collapse of endoplasmic reticulum. Mol Cell Neurosci (2009) 0.82

Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol (2013) 0.81

Effects of cotransfection of antisense-EGFR and wild-type PTEN cDNA on human glioblastoma cells. Neuropathology (2006) 0.81

[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas]. Zhonghua Zhong Liu Za Zhi (2011) 0.79

Overexpression of IL-7 enhances cisplatin resistance in glioma. Cancer Biol Ther (2012) 0.79

KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cells. Brain Pathol (2010) 0.78

Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors. Hum Pathol (2005) 0.78

Expression of CPEB4 in Human Glioma and Its Correlations With Prognosis. Medicine (Baltimore) (2015) 0.77

[Microsurgical technique of brain glioma---a report of 183 cases]. Ai Zheng (2004) 0.77

[Correlation of DNA-PK activity with anti-cancer drug-sensitivity in human gliomas]. Zhonghua Zhong Liu Za Zhi (2006) 0.76

Histone deacetylase inhibitor, 2-propylpentanoic acid, increases the chemosensitivity and radiosensitivity of human glioma cell lines in vitro. Chin Med J (Engl) (2012) 0.76

Cryptotanshinone Ameliorates Hepatic Normothermic Ischemia and Reperfusion Injury in Rats by Anti-mitochondrial Apoptosis. Biol Pharm Bull (2014) 0.76

Long-term molecular changes in WHO grade II astrocytomas following radiotherapy. Chin J Cancer (2012) 0.76

Essence of resistance to anti-angiogenic therapy in tumors. Chin Med J (Engl) (2011) 0.75

Identification of TPO receptors on central nervous system-a preliminary report. Zhongguo Shi Yan Xue Ye Xue Za Zhi (2004) 0.75

Neurosurgical interventions for patients with nasopharyngeal carcinoma: a single institution experience. World J Surg Oncol (2013) 0.75

Epidural Cystic Spinal Meningioma: A Case Report. Medicine (Baltimore) (2016) 0.75

[Comparison study on the diagnosis of erectile dysfunction with color Doppler ultrasonography and nocturnal electrobioimpedance volumetric assessment]. Zhonghua Nan Ke Xue (2006) 0.75

Sonographic study of the development of fetal corpus callosum in a Chinese population. J Clin Ultrasound (2009) 0.75

[Correlation between TGF- β1 expression and Treg cell infiltration in glioma]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi (2011) 0.75

[An allelotype study of primary and corresponding recurrent glioblastoma multiforme]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2003) 0.75

Lumbosacral clear-cell meningioma treated with subtotal resection and radiotherapy. J Clin Neurosci (2004) 0.75

[Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases]. Ai Zheng (2006) 0.75

[Microneurosurgical treatment for gliomas located in lateral fissure area]. Ai Zheng (2002) 0.75

[Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor]. Zhonghua Bing Li Xue Za Zhi (2007) 0.75

[Genome-wide genetic study of medulloblastoma using allelotype analysis]. Zhonghua Bing Li Xue Za Zhi (2004) 0.75

[Survival of newly diagnosed malignant glioma patients on combined modality therapy]. Zhonghua Yi Xue Za Zhi (2013) 0.75

[Molecular genetic studies on ganglioglioma]. Zhonghua Bing Li Xue Za Zhi (2005) 0.75

Schwannoma of the facial nerve involving the middle cranial fossa: case report. Chin Med J (Engl) (2007) 0.75